COST EFFECTIVENESS ANALYSIS IN HEALTH AND HEALTHCARE

Prerequisites & course information

Requisites: SOC/POP HLTH 797 and POP HLTH/B M I 552 Course Designation: Grad 50% - Counts toward 50% graduate coursework requirement Repeatable for Credit: No Last Taught: Fall 2026 Learning Outcomes: 1. Apply basic concepts of economic analysis to the assessment of medical technologies and healthcare interventions more broadly Audience: Graduate 2. Examine health outcomes on a range from objective measures of physical systems to subjective preference-based measures of health utility and describe the benefits and limitations of using quality-adjusted life years (QALYs) as a health outcome measure Audience: Graduate 3. Explain why we seek to obtain estimates of the “opportunity cost” of using health care resources, describe the process of “costing” in economic assessments of medical technologies and identify useful sources of information for obtaining cost information (and their limitations) Audience: Graduate 4. Describe how primary data from randomized controlled trials and observational studies can be designed to assess medical technologies and explain the advantages and disadvantages of different designs in terms of their internal and external validity and decision-relevance Audience: Graduate 5. Describe how evidence from secondary data can be integrated using meta-analysis and decision-analytic modeling methods to assess medical technologies and demonstrate basic ability to design and execute simple decision tree and Markov models for cost-effectiveness analysis Audience: Graduate Learning Outcomes: 1. Apply basic concepts of economic analysis to the assessment of medical technologies and healthcare interventions more broadly Audience: Graduate 2. Examine health outcomes on a range from objective measures of physical systems to subjective preference-based measures of health utility and describe the benefits and limitations of using quality-adjusted life years (QALYs) as a health outcome measure Audience: Graduate 3. Explain why we seek to obtain estimates of the “opportunity cost” of using health care resources, describe the process of “costing” in economic assessments of medical technologies and identify useful sources of information for obtaining cost information (and their limitations) Audience: Graduate 4. Describe how primary data from randomized controlled trials and observational studies can be designed to assess medical technologies and explain the advantages and disadvantages of different designs in terms of their internal and external validity and decision-relevance Audience: Graduate 5. Describe how evidence from secondary data can be integrated using meta-analysis and decision-analytic modeling methods to assess medical technologies and demonstrate basic ability to design and execute simple decision tree and Markov models for cost-effectiveness analysis Audience: Graduate